U.S. Mutation Detection Kits In Genome Editing Market Size & Outlook

The mutation detection kits in genome editing market in the United States is expected to reach a projected revenue of US$ 150,121.0 million by 2028. A compound annual growth rate of 16.6% is expected of the United States mutation detection kits in genome editing market from 2021 to 2028.

Revenue, 2020 (US$M)
$43,917.2
Forecast, 2028 (US$M)
$150,121.0
CAGR, 2021 - 2028
16.6%
Report Coverage
U.S.

U.S. mutation detection kits in genome editing market highlights

  • The U.S. mutation detection kits in genome editing market generated a revenue of USD 43,917.2 million in 2020 and is expected to reach USD 150,121.0 million by 2028.
  • The U.S. market is expected to grow at a CAGR of 16.6% from 2021 to 2028.
  • In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2020.
  • Meganuclease is the most lucrative technology segment registering the fastest growth during the forecast period.

Mutation detection kits in genome editing market data book summary

Market revenue in 2020USD 43,917.2 million
Market revenue in 2028USD 150,121.0 million
Growth rate16.6% (CAGR from 2020 to 2028)
Largest segment(crispr)/cas9
Fastest growing segmentMeganuclease
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentation(CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease
Key market players worldwideThermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC

Other key industry trends

  • In terms of revenue, U.S. accounted for 34.6% of the global mutation detection kits in genome editing market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In North America, U.S. mutation detection kits in genome editing market is projected to lead the regional market in terms of revenue in 2028.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 23,429.3 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mutation Detection Kits In Genome Editing Market Scope

Mutation detection kits in genome editing market segmentation & scope
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
ZFN
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Others
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations

Mutation Detection Kits In Genome Editing Market Companies

Name Profile # Employees HQ Website

U.S. mutation detection kits in genome editing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.


(crispr)/cas9 was the largest segment with a revenue share of 43% in 2020. Horizon Databook has segmented the U.S. mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.


The U.S. dominated North America’s market due to its extensive research activities in genomics, oncology, and whole-genome sequencing. Other factors, such as sophisticated research & medical infrastructure, funding, skilled personnel, and companies pushing for better research methods to identify innovative technologies for diagnosis & therapies, can be attributed to the significant adoption of mutation detection kits in genome editing market in this country.

The large revenue share of the U.S. can also be attributed to the local presence of market leaders, such as Thermo Fisher Scientific, Lucigen Corporation, GeneScript, and Integrated DNA Technologies, Inc., which are involved in the development and supply of mutation detection kits.

The regulatory paradigm followed for gene editing in the U.S. is distributed along the coordinated framework of Department of Agriculture (USDA), Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA), rather than on biosafety law. This framework is significantly product-based, and the process comes into picture for regulatory assessment.

Reasons to subscribe to U.S. mutation detection kits in genome editing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. mutation detection kits in genome editing market databook

  • Our clientele includes a mix of mutation detection kits in genome editing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. mutation detection kits in genome editing market size, by technology, 2017-2028 (US$M)

U.S. Mutation Detection Kits In Genome Editing Market Outlook Share, 2020 & 2028 (US$M)

U.S. mutation detection kits in genome editing market size, by technology, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more